The agreement allows for potential expansion into wider research and further programmes. Credit: M Isolation photo / Shutterstock.com. · Hospital Management · M Isolation photo / Shutterstock.com.
PETACH TIKVA, Israel, April 16, 2026 /PRNewswire/ -- Interna Therapeutics, a clinical stage biotechnology company advancing its Molecular Nano Motor (MNM) intracellular delivery platform, today ...
UTRECHT, The Netherlands--(BUSINESS WIRE)--InteRNA Technologies, a clinical-stage biotech company developing microRNA (miRNA)-based therapeutics with a focus on cancer, announced today the appointment ...
PETACH TIKVAH, Israel, March 23, 2026 /PRNewswire/ -- Interna Therapeutics, a clinical-stage biopharmaceutical company announced today that it has signed an agreement with the University of Oxford to ...
UTRECHT, The Netherlands--(BUSINESS WIRE)--InteRNA Technologies announced today the closing of an extended Series B financing round amounting to EUR 18.5M in total. This Series B round was led by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results